跳至主要内容
临床试验/NCT06167616
NCT06167616已完成不适用

Infections and Genetic Susceptibility in LADA and Type 2 Diabetes

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 5,048 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,048
试验地点
1
主要终点
LADA

研究概览

简要总结

Infections are proposed risk factors for type 1 diabetes in children. The investigators will examine whether a diagnosis of infectious disease also confers an increased risk of latent autoimmune diabetes in adults.

详细描述

The investigators will use data from a population-based Swedish case-control study (ESTRID) with incident cases of LADA (n=597) and matched controls (n=2386). History of infectious disease are ascertained through national and regional patient registers. The investigators will estimate adjusted odds ratios (OR) with 95% CI for ≥1 respiratory (any/upper/lower), gastrointestinal, herpetic, other or any infectious disease episode, or separately, for 1 and ≥2 infectious disease episodes, within 0-1, 1-3, 3-5 and 5-10 years before LADA diagnosis/matching. Stratified analyses will be performed based on HLA risk genotypes and GADA levels.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 35 years or older, residing in Scania or Uppsala county.

排除标准

  • Less than 35 years

结局指标

主要结局

LADA

时间窗: Up to 10 years

≥35 years at diagnosis, GADA positivity (≥10 U/ml) and C-peptide concentrations of ≥0.2 nmol/L (IMMULITE) or ≥0.3 nmol/L (Cobas).

次要结局

  • Type 2 diabetes(Up to 10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sofia Carlsson

Associate professor

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验